Scholars Central

EditorialPublished 3 Aug 2020

Editorial Note: Brain disorders and Therapy

Authors: Sarilla Gowthami

Brain Disorders & Therapy

Volume 9 · Issue 3 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Neuromuscular diseases have a considerable burden on patients, their caregivers, and healthcare systems. These diseases are largely genetic, degenerative, and life-threatening or life-altering. The dystrophy Association (MDA) has been at the forefront of research, therapy development, and early intervention for neuromuscular disease since its foundation in 1950. The MDA Clinical & Scientific Conference, held on March 22–25, 2020, in Orlando, Florida, will mark the 70th anniversary of the MDA. Huge progress has been made in recent years, but the sector has reached a crossroads—strong advocacy programmes from the MDA and other stakeholders are going to be essential to continue the success stories of neuromuscular research and to make sure the readiness of systems to translate these breakthroughs to clinical practice.

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Brain Disorders & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBrain Disorders & Therapy
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Sarilla Gowthami”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels